Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44346 clinical trials with a EudraCT protocol, of which 7374 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,346)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,346 result(s) found. Displaying page 998 of 2,218.

EudraCT Number: 2007-005651-41

Sponsor Protocol Number: 2007-185

Start Date*: 2008-01-24

Sponsor Name:Peter Lommer Kristensen

Full Title: Erythropoietins betydning for den kognitive funktion hos diabetikere under eksperimentel hypoglykæmi.

Medical condition: Type 1 Diabetes / hypoglycaemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10012601	Diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: (No results available)

EudraCT Number: 2008-006446-25

Sponsor Protocol Number: VX08-809-101

Start Date*: 2009-08-26

Sponsor Name:Vertex Pharmaceuticals Incorporated

Full Title: A randomized, double-blind, placebo-controlled, multiple dose study of VX-809 to evaluate safety, pharmacokinetics, and pharmacodynamics of VX-809 in cystic fibrosis subjects homozygous for the del...

Medical condition: Cystic Fibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10011762	Cystic fibrosis	LLT
	9.1		10011764	Cystic fibrosis NOS	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: NL (Completed) DE (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2007-003770-25	Sponsor Protocol Number: 3959	Start Date*: 2008-02-21
Sponsor Name:Hôpitaux Universitaires de Strasbourg
Full Title: ACIDE TRANEXAMIQUE VERSUS PLACEBO DANS LA REDUCTION DES SAIGNEMENTS PERIOPERATOIRES APRES HEPATECTOMIES MAJEURES : ETUDE PROSPECTIVE RANDOMISEE EN DOUBLE AVEUGLE.
Medical condition: Patients devant bénéficier d'une résection hépatique majeure (≥ 3 segments hépatiques).
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2007-006345-40

Sponsor Protocol Number: rhASA-03

Start Date*: 2008-08-26

Sponsor Name:Shire Pharmaceutical Ireland Limited

Full Title: A single center, open-label, non-randomized, uncontrolled, multiple-dose study of the efficacy and long-term safety of Metazym (recombinant human arylsulfatase A or rhASA) for the treatment of pati...

Medical condition: Metachromatic Leukodystrophy (MLD) in late infantile patients

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10024381	Leukodystrophy	LLT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: View results

EudraCT Number: 2007-006117-16	Sponsor Protocol Number: Puranik 07-03/23	Start Date*: 2008-07-31
Sponsor Name:Betsi Cadwaladr University Health Board
Full Title: A prospective, randomised, phase IV, open label clinical trial to study the therapeutic use of buprenorphine 20 mg (BuTrans 20µg/h) matrix transdermal patch in the management of post tonsillectomy ...
Medical condition: post-tonsillectomy pain
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2007-005821-31	Sponsor Protocol Number: GA0706	Start Date*: 2008-01-15
Sponsor Name:Reckitt Benckiser Healthcare UK) Limited [...] 1. Reckitt Benckiser Healthcare UK) Limited 2. Reckitt Benckiser Healthcare (UK) Limited
Full Title: A single-centre randomised, partially blind, single dose, crossover pilot study investigating the use of stopwatches to assess the onset of action of soothing and cooling of Gaviscon Peppermint Liq...
Medical condition: Symptoms of heartburn
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2007-004984-23	Sponsor Protocol Number: 191/2006	Start Date*: 2008-05-08
Sponsor Name:Department of Obstetrics and Gynecology, Oulu University Hospital
Full Title: Ehkäisylaastarin, ehkäisytabletin ja ehkäisyrenkaan vaikutukset hormonaalisiin, tulehduksellisiin ja aineenvaihdunnallisiin parametreihin hedelmällisessä iässä olevilla terveillä naisilla.
Medical condition: Perusterveitä hedelmällisessä iässä olevia naisia.
Disease:
Population Age: Adults		Gender: Female
Trial protocol: FI (Completed)
Trial results: View results

EudraCT Number: 2007-005178-30

Sponsor Protocol Number: LRS-01-07-02

Start Date*: 2008-01-09

Sponsor Name:Life Recovery Systems

Full Title: Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients with Intravenous Infusion of Magnesium Sulfate

Medical condition: Post resusucitation disease after resuscitation from cardiac arrest

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10007515	Cardiac arrest	LLT
	9.1		10029286	Neurologic disorder NOS	LLT
	9.1		10059485	Therapeutic hypothermia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2007-005627-15

Sponsor Protocol Number: CIT07-FB/CREIN

Start Date*: 2007-12-19

Sponsor Name:CHRU de TOURS

Full Title: Evaluation de l'échographie de contraste pour l'appréciation précoce de l'effet d'un traitement anti-angiogénique sur le carcinome rénal avancé

Medical condition: adenocarcinome rénal métastatique à cellule claire

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10050018	Renal cancer metastatic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2007-004702-27

Sponsor Protocol Number: BV-2007/02

Start Date*: 2008-03-17

Sponsor Name:OM PHARMA

Full Title: Multicentre, double-blind, placebo-controlled, randomised clinical study of Broncho-Vaxom® (Broncho-Munal®) for the protection from acute exacerbations of COPD

Medical condition: Acute exacerbations in patients suffering from COPD (stage II - III according GOLD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10009033	Chronic obstructive pulmonary disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) AT (Completed) BE (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2007-001951-20

Sponsor Protocol Number: UCL/06/053

Start Date*: 2008-03-12

Sponsor Name:University College London

Full Title: A phase I and randomised phase II study of Docetaxel and RAD001 (Everolimus) in advanced/recurrent or metastatic squamous cell carcinoma of the head and neck

Medical condition: Locally advanced or metastatic squamous cell carcinoma of the head and neck

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10063569	Metastatic squamous cell carcinoma	LLT
	9.1		10060121	Squamous cell carcinoma of head and neck	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2007-006304-37	Sponsor Protocol Number: 19.4.324	Start Date*: 2008-03-19
Sponsor Name:NV Organon
Full Title: A multi-center, randomized, parallel-group, active-controlled, safety-assessor blinded trial, comparing the efficacy and safety of 2.0 mg.kg-1 sugammadex with 50 μg.kg-1 neostigmine administered at...
Medical condition: Not applicable
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: DK (Completed) BE (Completed)
Trial results: View results

EudraCT Number: 2007-001269-14

Sponsor Protocol Number: AI463-137

Start Date*: 2008-04-29

Sponsor Name:Bristol-Myers Squibb International Corporation

Full Title: A Comparative Study of the Antiviral Efficacy and Safety of Entecavir Plus Tenofovir versus Adefovir Added to Continuing Lamivudine in Adults with Lamivudine Resistant Chronic Hepatitis B Virus Inf...

Medical condition: HEPATITIS B VIRUS

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10008910	Chronic hepatitis B	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) DE (Prematurely Ended) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2006-003103-39

Sponsor Protocol Number: AR003

Start Date*: 2007-04-19

Sponsor Name:University of Glasgow & Greater Glasgow Health Board

Full Title: Effect of statins on asthma control and airway inflammation in smokers with asthma

Medical condition: Chronic Asthma (smokers),COPD.

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10003553	Asthma	LLT
	9.1		10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2007-003858-29	Sponsor Protocol Number: CISCA-Studie“ Protokollversion 4.0	Start Date*: 2008-02-27
Sponsor Name:Universitätsklinikum Tübingen, Medizinische Klinik I
Full Title: Prospektive multizentrische Phase-III-Studie zur ambulanten Therapie mit Capecitabin versus Cisplatin plus Capecitabin beim fortgeschrittenen Adenokarzinom der Gallenblase und Gallenwege („CISCA-St...
Medical condition: Karzinome der Gallenblase, Karzinome der extrahepatischen Gallengänge
Disease:
Population Age:		Gender: Male, Female
Trial protocol: AT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2007-005936-99

Sponsor Protocol Number: C-07-16

Start Date*: 2008-11-19

Sponsor Name:Alcon Research, Ltd.

Full Title: Effects of Topical Hypotensive Drugs on Circadian Ocular Perfusion Pressure and Ocular Blood Flow in Patients with Open-Angle Glaucoma

Medical condition: Open-Angle Glaucoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10030856	Open-angle glaucoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GR (Completed)

Trial results: View results

EudraCT Number: 2008-001309-40	Sponsor Protocol Number: Progen08	Start Date*: 2008-06-10
Sponsor Name:Linköping university
Full Title: Pharmacogenetic of propofol
Medical condition: No medical condition or disease are investigated. This study will investigated the polymorfism in genes that are involved in the metabolism of a anastetic agent-propofol.
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2007-004888-22	Sponsor Protocol Number: CHCD122A2103	Start Date*: 2008-03-27
Sponsor Name:Novartis Pharma AG
Full Title: A phase IA/II, multi-center, open-label study of HCD122 administered intravenously once weekly for four weeks in adult patients with advanced non-Hodgkin's or Hodgkin's lymphoma who have progressed...
Medical condition: Advanced non Hodgkin's or Hodgkin's lymphoma
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Completed) DE (Completed) FR (Completed) GB (Completed)
Trial results: View results

EudraCT Number: 2007-002858-37	Sponsor Protocol Number: DOBESILATO500/2	Start Date*: 2008-01-23
Sponsor Name:FUNDACIÓN IBEROAMERICANA ITACA
Full Title: ENSAYO CLÍNICO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, PARALELO, COMPARADO CON PLACEBO PARA VALORAR LA EFICACIA DEL DOBESILATO CÁLCICO EN EL TRATAMIENTO DE LAS ÚLCERAS SECUNDARIAS A INSUFICIENCIA...
Medical condition: Úlceras cutáneas secundarias a insuficiencia venosa crónica (Skin ulcers secondaries to chronic venous insufficiency)
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-003795-35

Sponsor Protocol Number: Griac001

Start Date*: 2006-10-03

Sponsor Name:University Medical Center Groningen

Full Title: Mannitol inhalations as a faster procedure for testing of airways hyperresponsiveness

Medical condition: Detection of airway hyperresponsiveness in patients with asthma or COPD

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10003553	Asthma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Thu Jun 26 08:12:35 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA